MK-8722 (DC12020) chemical structure
Chemical structureResearch use only
CAT. NO. DC12020Featured

MK-8722

Pack size & price

USD
Ready-made solution
Total$850
We match the best price and quality on market.
Product overview

Description & Application

MK-8722 is a direct allosteric activator of mammalian AMPK complexes for metabolic signaling and glucose-homeostasis research.

ParameterValue
Chemical Name(3R,3aR,6R,6aR)-6-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-imidazo[4,5-b]pyridin-2-yl)oxy)hexahydrofuro[3,2-b]furan-3-ol
CAS No.1394371-71-1
SynonymsMK-8722,MK8722,MK 8722,1394371-71-1
FormulaC24H20ClN3O4
M.Wt449.89
SMILESClC1=C2C(NC(O[C@@H]3CO[C@@]4([H])[C@]3([H])OC[C@H]4O)=N2)=NC=C1C5=CC=C(C6=CC=CC=C6)C=C5
PurityOn request
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Pan-AMPK activation · Literature evidence

Biological Activity

MK-8722 is a direct allosteric activator of mammalian AMPK complexes for metabolic signaling and glucose-homeostasis research. MK-8722 acted as a direct allosteric pan-AMPK activator.

In Vitro

EndpointModel / conditions / sourceReported result
AMPK activationBiochemical characterization of all 12 mammalian AMPK complexes. [1]MK-8722 acted as a direct allosteric pan-AMPK activator.

In Vivo

EndpointModel / conditions / sourceReported result
Metabolic responseRodent and rhesus-monkey studies, including diabetic monkeys. [1]Stimulated insulin-independent skeletal-muscle glucose uptake and glycogen synthesis, with durable glycemic improvement.
Glycemic tolerabilityReported cross-species experiments. [1]No evidence of hypoglycemia was observed under the studied regimens.
Cardiac limitationCardiac assessments after systemic activation. [1]Cardiac hypertrophy and increased cardiac glycogen accompanied metabolic effects, although apparent functional sequelae were not detected in the reported experiments.

Interpretation

The cardiac findings are a material limitation; improved glucose control does not imply a favorable overall safety profile.

Original studies

References

  1. Myers RW, et al. Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. Science (New York, N.Y.) (2017).

Product documentation

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

For additional quantities or product documentation, contact info@dcchemicals.com.

Related research products

Laropiprant chemical structureDC1009

Laropiprant

Laropiprant is a DP1 receptor antagonist for prostanoid signaling and platelet-function research. Its effects on platelet activation vary with agonist and concentration.

View activity & prices

Cart

Request quotation